Correlation Between Destiny Tech100 and Santen Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Destiny Tech100 and Santen Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Destiny Tech100 and Santen Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Destiny Tech100 and Santen Pharmaceutical Co, you can compare the effects of market volatilities on Destiny Tech100 and Santen Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Destiny Tech100 with a short position of Santen Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Destiny Tech100 and Santen Pharmaceutical.

Diversification Opportunities for Destiny Tech100 and Santen Pharmaceutical

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Destiny and Santen is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Destiny Tech100 and Santen Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Santen Pharmaceutical and Destiny Tech100 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Destiny Tech100 are associated (or correlated) with Santen Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Santen Pharmaceutical has no effect on the direction of Destiny Tech100 i.e., Destiny Tech100 and Santen Pharmaceutical go up and down completely randomly.

Pair Corralation between Destiny Tech100 and Santen Pharmaceutical

Given the investment horizon of 90 days Destiny Tech100 is expected to generate 8.78 times more return on investment than Santen Pharmaceutical. However, Destiny Tech100 is 8.78 times more volatile than Santen Pharmaceutical Co. It trades about 0.39 of its potential returns per unit of risk. Santen Pharmaceutical Co is currently generating about -0.3 per unit of risk. If you would invest  1,178  in Destiny Tech100 on August 28, 2024 and sell it today you would earn a total of  3,211  from holding Destiny Tech100 or generate 272.58% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Destiny Tech100  vs.  Santen Pharmaceutical Co

 Performance 
       Timeline  
Destiny Tech100 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Destiny Tech100 are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Destiny Tech100 showed solid returns over the last few months and may actually be approaching a breakup point.
Santen Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Santen Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Destiny Tech100 and Santen Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Destiny Tech100 and Santen Pharmaceutical

The main advantage of trading using opposite Destiny Tech100 and Santen Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Destiny Tech100 position performs unexpectedly, Santen Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Santen Pharmaceutical will offset losses from the drop in Santen Pharmaceutical's long position.
The idea behind Destiny Tech100 and Santen Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Correlations
Find global opportunities by holding instruments from different markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals